Treatment Guidelines and Consensus Paper
The development and formulation of the WFSBP Treatment Guidelines and Consensus Papers are a major focus of the federation.
They are developed by the WFSBP Task Forces and provide a clear and top-quality treatment orientation for clinicians around the world.
Alzheimer's disease and dementias
Biological treatment of Alzheimer’s disease and other dementias (2011)
Anxiety disorders
Treatment of anxiety, obsessive-compulsive and posttraumatic
stress disorders (2008)
Bipolar disorders
Acute and longterm treatment of mixed states in bipolar disorder (2017)
Maintenance treatment of bipolar disorders (2013)
Acute bipolar depression (2010)
Treatment of acute mania (2009)
Clinical Guideline Development
WFSBP guidelines on how to grade treatment evidence for clinical guideline development (2020)
Brain stimulation treatments
Brain stimulation treatments in psychiatry (2010)
Depressive disorders
Treatment of unipolar depressive disorders in primary care (2007)
Eating disorders
Pharmacological treatment of eating disorders (2011)
Paraphilias
Treatment of paraphilias (2020)
Treatment of paraphilias (2016)
Treatment of paraphilas (2010)
Personality disorders
Treatment of personality disorders (2007)
Schizophrenia
Long-term treatment of schizophrenia and
management of antipsychotic-induced side effects (2013)
Acute treatment of schizophrenia and
management of treatment resistance (2012)
Substance use disorders
Treatment of substance use and related disorders:
Alcoholism, first revision (2017)
Treatment of substance use and related disorders:
Opioid dependence (2011)
Treatment of substance use and related disorders:
Alcoholism (2008)
Women's Mental Health
Consensus Paper related to the Task Force on Biological Markers
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias (2017)
Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms (2017)
Biological markers for anxiety disorders, OCD and PTSD – a consensus statement. Part I: Neuroimaging and genetics (2016)
Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition (2016)
Biological markers in schizophrenia, part I: Neurophysiology (2015)
Biological markers for alcoholism (2014)
Biomarkers for attention-deficit/hyperactivity disorder (ADHD) (2012)
Biological markers in depression (2007)
The role of CSF and blood analysis in the early and differential diagnosis of dementia (2005)
Consensus Papers related to the Task Force on Genetics
Genetics of schizophrenia: A consensus paper of the WFSBP Task Force on Genetics (2016)
Consensus Papers related to the Task Force on Men’s Mental Health
Prevention of homicidal behaviour in men with psychiatric disorders (2015)
Consensus Paper related to the Task Force on Psychopathlogy
Psychopathology in the 21st century (2010)
Consensus Papers related to the Task Force on Unipolar depressive disorders
Agitation Consensus